Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 3
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.
Acute Migraine
Estimated
~$10 – $8,750
Kallyope Inc.NCT07674654
Phase 1
A Prospective, Open-Label Study Evaluating the Effectiveness of Rimegepant ODT or Zavegepant Nasal Spray for Acute Treatment of Migraine in the Emergency Department
Prospective, single-site, open-label, non-controlled pilot study consisting of two parallel trials. Participants will receive rimegepant or zavegepant for acut…
MigraineMigraine DiseaseMigraine in Adults+4 more
Estimated
~$10 – $6,250
University of South FloridaNCT07667621